Cargando…

The drug efficacy testing in 3D cultures platform identifies effective drugs for ovarian cancer patients

Most patients with advanced ovarian cancer (OC) relapse and progress despite systemic therapy, pointing to the need for improved and tailored therapy options. Functional precision medicine can help to identify effective therapies for individual patients in a clinically relevant timeframe. Here, we p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Åkerlund, Emma, Gudoityte, Greta, Moussaud-Lamodière, Elisabeth, Lind, Olina, Bwanika, Henri Colyn, Lehti, Kaisa, Salehi, Sahar, Carlson, Joseph, Wallin, Emelie, Fernebro, Josefin, Östling, Päivi, Kallioniemi, Olli, Joneborg, Ulrika, Seashore-Ludlow, Brinton
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618545/ https://www.ncbi.nlm.nih.gov/pubmed/37907613 http://dx.doi.org/10.1038/s41698-023-00463-z

Ejemplares similares

Miniaturized and multiplexed high-content screening of drug and immune sensitivity in a multichambered microwell chip
por: Sandström, Niklas, et al.
Publicado: (2022)

Breeze 2.0: an interactive web-tool for visual analysis and comparison of drug response data
por: Potdar, Swapnil, et al.
Publicado: (2023)

PFKFB3 Inhibition Sensitizes DNA Crosslinking Chemotherapies by Suppressing Fanconi Anemia Repair
por: Ninou, Anna Huguet, et al.
Publicado: (2021)

FGFR4 phosphorylates MST1 to confer breast cancer cells resistance to MST1/2-dependent apoptosis
por: Turunen, S. Pauliina, et al.
Publicado: (2019)

Differences in Administration of Methotrexate and Impact on Outcome in Low-Risk Gestational Trophoblastic Neoplasia
por: Wallin, Emelie, et al.
Publicado: (2022)

Multiomics characterization implicates PTK7 in ovarian cancer EMT and cell plasticity and offers strategies for therapeutic intervention
por: Raivola, Juuli, et al.
Publicado: (2022)

Impact of normalization methods on high-throughput screening data with high hit rates and drug testing with dose–response data
por: Mpindi, John-Patrick, et al.
Publicado: (2015)

Breeze: an integrated quality control and data analysis application for high-throughput drug screening
por: Potdar, Swapnil, et al.
Publicado: (2020)

Alpha-synuclein and tau: teammates in neurodegeneration?
por: Moussaud, Simon, et al.
Publicado: (2014)

Prediction model for drug response of acute myeloid leukemia patients
por: Trac, Quang Thinh, et al.
Publicado: (2023)

A Portable, Negative-Pressure Actuated, Dynamically Tunable Microfluidic Droplet Generator
por: Trossbach, Martin, et al.
Publicado: (2022)

Drug sensitivity testing on patient-derived sarcoma cells predicts patient response to treatment and identifies c-Sarc inhibitors as active drugs for translocation sarcomas
por: Brodin, Bertha A., et al.
Publicado: (2019)

Integrative multi-omics and drug response profiling of childhood acute lymphoblastic leukemia cell lines
por: Leo, Isabelle Rose, et al.
Publicado: (2022)

Chemical Biology Drug Sensitivity Screen Identifies Sunitinib as Synergistic Agent with Disulfiram in Prostate Cancer Cells
por: Ketola, Kirsi, et al.
Publicado: (2012)

Phosphorylation by PINK1 Releases the UBL Domain and Initializes the Conformational Opening of the E3 Ubiquitin Ligase Parkin
por: Caulfield, Thomas R., et al.
Publicado: (2014)

High-throughput ex vivo drug testing identifies potential drugs and drug combinations for NRAS-positive malignant melanoma
por: Kohtamäki, Laura, et al.
Publicado: (2021)

Immediate Adaptation Analysis Implicates BCL6 as an EGFR-TKI Combination Therapy Target in NSCLC
por: Zhou Tran, Yan, et al.
Publicado: (2020)

Iliaco-enteric fistula after robot-assisted comprehensive surgical staging of endometrial cancer: a case report
por: Salehi, Sahar, et al.
Publicado: (2018)

Drug Target Commons: A Community Effort to Build a Consensus Knowledge Base for Drug-Target Interactions
por: Tang, Jing, et al.
Publicado: (2018)

Identification of structural features in chemicals associated with cancer drug response: a systematic data-driven analysis
por: Khan, Suleiman A., et al.
Publicado: (2014)

Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors
por: Kolberg, Matthias, et al.
Publicado: (2017)

Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance
por: Pietilä, Elina A., et al.
Publicado: (2021)

Targeting SAMHD1 with hydroxyurea in first‐line cytarabine‐based therapy of newly diagnosed acute myeloid leukaemia: Results from the HEAT‐AML trial
por: Jädersten, Martin, et al.
Publicado: (2022)

Adaptive RSK‐EphA2‐GPRC5A signaling switch triggers chemotherapy resistance in ovarian cancer
por: Moyano‐Galceran, Lidia, et al.
Publicado: (2020)

Focus on the Tumour Periphery in MRI Evaluation of Soft Tissue Sarcoma: Infiltrative Growth Signifies Poor Prognosis
por: Fernebro, Josefin, et al.
Publicado: (2006)

Genetic Profiling Differentiates Second Primary Tumors from Metastases in Adult Metachronous Soft Tissue Sarcoma
por: Fernebro, Josefin, et al.
Publicado: (2008)

High-Throughput 3D Screening Reveals Differences in Drug Sensitivities between Culture Models of JIMT1 Breast Cancer Cells
por: Hongisto, Vesa, et al.
Publicado: (2013)

Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancer
por: Kangaspeska, Sara, et al.
Publicado: (2016)

Incidence of and survival after surgical intervention for bowel obstruction in women with advanced ovarian cancer
por: Pálsdóttir, Kolbrún, et al.
Publicado: (2023)

Computational and Experimental Druggability Assessment of Human DNA Glycosylases
por: Michel, Maurice, et al.
Publicado: (2019)

Systemic Analysis of Gene Expression Profiles Identifies ErbB3 as a Potential Drug Target in Pediatric Alveolar Rhabdomyosarcoma
por: Nordberg, Janne, et al.
Publicado: (2012)

STRN-ALK rearranged pediatric malignant peritoneal mesothelioma – Functional testing of 527 cancer drugs in patient-derived cancer cells
por: Murumägi, Astrid, et al.
Publicado: (2021)

Drug use in pregnant women—a pilot study of the coherence between reported use of drugs and presence of drugs in plasma
por: Wolgast, Emelie, et al.
Publicado: (2017)

A Comprehensive Panel of Three-Dimensional Models for Studies of Prostate Cancer Growth, Invasion and Drug Responses
por: Härmä, Ville, et al.
Publicado: (2010)

Western Diet Decreases Hepatic Drug Metabolism in Male LDLr(−/−)ApoB(100/100) Mice
por: Koponen, Markus, et al.
Publicado: (2023)

Mesothelin Expression in Patients with High-Grade Serous Ovarian Cancer Does Not Predict Clinical Outcome But Correlates with CD11c(+) Expression in Tumor
por: Magalhaes, Isabelle, et al.
Publicado: (2020)

European multidisciplinary tumor boards support cross-border networking and increase treatment options for patients with rare gynecological tumors
por: Joneborg, Ulrika, et al.
Publicado: (2023)

MTH1 Inhibitor TH1579 Induces Oxidative DNA Damage and Mitotic Arrest in Acute Myeloid Leukemia
por: Sanjiv, Kumar, et al.
Publicado: (2021)

Aggressive and recurrent ovarian cancers upregulate ephrinA5, a non-canonical effector of EphA2 signaling duality
por: Jukonen, Joonas, et al.
Publicado: (2021)

Comprehensive data-driven analysis of the impact of chemoinformatic structure on the genome-wide biological response profiles of cancer cells to 1159 drugs
por: Khan, Suleiman A, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_uaioo7i6r7s276hefj9u25s90u